格力地產(600185.SH)擬斥資17.255億元購買科華生物18.63%股權
格隆匯5月10日丨格力地產(600185.SH)發佈公告,公司全資子公司珠海保聯資產管理有限公司擬通過協議方式購買 League Agent (HK) Limited 持有的科華生物(002022.SZ)9586.3038萬股股份(佔科華生物總股本的18.63%),購買價格約為人民幣 17.255億元。
公告表示,為進一步完善產業佈局,根據十三五規劃,公司幾年前已在海內外開始佈局生物醫藥和醫療健康產業。科華生物是一家立足於精準醫療領域,擁有完整醫療診斷產品及整體解決方案的中國體外診斷公司,是國內為數不多的能夠在分子、生化及免疫等領域,均具備全自動、靈活通量檢測系統解決方案和供應能力的公司,在國內體外臨牀診斷行業中擁有顯著的綜合性競爭優勢。
本次股份收購系公司根據自身戰略部署,向生物醫藥和醫療健康領域佈局邁出實質性的步伐、完善和擴展大健康板塊產業佈局的重要舉措。當前,珠海正努力打造集成電路、生物醫藥、新材料、新能源、高端打印設備等 5 個千億級產業集羣,通過本次收購,公司能夠貫徹落實珠海市發展戰略,通過資本和產業的有效聯動,進一步擴大企業競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.